ARTICLE | Strategy
BioMarin chronicles
July 11, 2005 7:00 AM UTC
On the back of positive news for its enzyme replacement therapies, BMRN has almost made a round trip since it announced last April that it would focus on pediatrics. A. 4/21/04 - BMRN says it will pa...